CIK 0001994702 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +735,984 | 735,984 | ||
| 2024-02-12 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series A-1 Redeemable Convertible Preferred Stock | −4,401,771 | 0 | ||
| 2024-02-12 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series A-2 Redeemable Convertible Preferred Stock | −8,830,901 | 0 | ||
| 2024-02-12 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −4,006,624 | 0 | ||
| 2024-02-12 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −3,349,538 | 0 | ||
| 2024-02-12 | Vida Ventures, LLC 10% owner | Conversion | +4,523,924 | 4,523,924 | ||
| 2024-02-12 | Vida Ventures, LLC 10% owner | Purchase | +252,553 | $22.00 | $5.6M | 252,553 |
| 2024-02-12 | Vida Ventures, LLC 10% owner | Purchase | +583 | $22.00 | $13K | 583 |
| 2024-02-12 | Vida Ventures, LLC 10% owner | Conversion · Series A-1 Redeemable Convertible Preferred Stock | −4,401,771 | 0 | ||
| 2024-02-12 | Vida Ventures, LLC 10% owner | Conversion · Series A-2 Redeemable Convertible Preferred Stock | −8,830,901 | 0 | ||
| 2024-02-12 | Vida Ventures, LLC 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −7,356,162 | 0 | ||
| 2024-02-12 | Cohen Fred E Director | Conversion | +4,523,924 | 4,523,924 | ||
| 2024-02-12 | Cohen Fred E Director | Conversion · Series A-1 Redeemable Convertible Preferred Stock | −4,401,771 | 0 | ||
| 2024-02-12 | Cohen Fred E Director | Conversion · Series A-2 Redeemable Convertible Preferred Stock | −8,830,901 | 0 | ||
| 2024-02-12 | Cohen Fred E Director | Conversion · Series B Redeemable Convertible Preferred Stock | −7,356,162 | 0 | ||
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion | +3,787,940 | 3,787,940 | ||
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion | +735,984 | 735,984 | ||
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion · Series A-1 Redeemable Convertible Preferred Stock | −4,401,771 | 0 | ||
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion · Series A-2 Redeemable Convertible Preferred Stock | −8,830,901 | 0 | ||
| 2024-02-12 | SEIDENBERG BETH C Director | Conversion · Series B Redeemable Convertible Preferred Stock | −4,006,624 | 0 |
Page 4 of 5 · 91 trades